Literature DB >> 9210094

Evidence of an association between functional abnormalities and defective diacylglycerol kinase activity in peripheral blood neutrophils from patients with localized juvenile periodontitis.

H M Hurttia1, L M Pelto, L Leino.   

Abstract

Peripheral neutrophils from patients with localized juvenile periodontitis (LJP) show functional abnormalities, such as impaired locomotion and enhanced respiratory burst activity. A defect in intracellular signalling mechanism has been proposed to be responsible for some changes, but direct evidence is lacking. In this study we have determined the activity of diacylglycerol (DAG) kinase, an enzyme controlling the DAG/protein kinase C (PKC) pathway, in crude cytosolic and membrane fractions of neutrophils from 5L JP patients and age and gender-matched normal individuals. No difference was observed in the DAG kinase activity in subcellular fractions from unstimulated cells between the 2 groups. When normal neutrophils were stimulated with N formyl-methionyl-leucyl-phenylalanine (FMLP), the enzyme activity was markedly increased in both subcellular fractions. In contrast, neutrophils from 3 of the 5 LJP patients tested completely failed to rise the DAG kinase activity upon chemoattractant stimulation. These data indicate that in some LJP patients the neutrophil DAG kinase may be defective. To examine whether a decrease in DAG kinase activity could account for some neutrophil abnormalities seen in LJP, normal neutrophils were treated with R59022, a DAG kinase inhibitor, that has been shown to reduce DAG kinase activity in human neutrophils. Upon stimulation with FMLP, R59022-treated normal neutrophils showed significantly reduced chemotactic response and enhanced respiratory burst activity, two typical functional abnormalities featured by LJP cells. It is concluded that a defect in DAG kinase may cause, through an abnormal accumulation of the endogenous PKC activator DAG some of the functional changes observed in neutrophils from LJP patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210094     DOI: 10.1111/j.1600-0765.1997.tb00550.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  6 in total

1.  Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients.

Authors:  Jens Martin Herrmann; Alpdogan Kantarci; Heidi Long; John Bernardo; Hatice Hasturk; Lewis V Wray; Elizabeth R Simons; Thomas E Van Dyke
Journal:  J Leukoc Biol       Date:  2005-06-03       Impact factor: 4.962

2.  Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Authors:  Salma Al-Darmaki; Kandi Knightshead; Yuichi Ishihara; Al Best; Harvey A Schenkein; John G Tew; Suzanne E Barbour
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

3.  A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage.

Authors:  Karsten Gronert; Alpdogan Kantarci; Bruce D Levy; Clary B Clish; Sabine Odparlik; Hatice Hasturk; John A Badwey; Sean P Colgan; Thomas E Van Dyke; Charles N Serhan
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 4.  DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases.

Authors:  Gianluca Baldanzi; Mario Malerba
Journal:  Int J Mol Sci       Date:  2019-11-13       Impact factor: 5.923

5.  Assessment of peripheral neutrophil functions in patients with localized aggressive periodontitis in the Indian population.

Authors:  Rahul S Bhansali; R K Yeltiwar; K G Bhat
Journal:  J Indian Soc Periodontol       Date:  2013-11

6.  Evaluation of peripheral neutrophil functions in aggressive periodontitis patients and their family members in Indian population: An assessment of neutrophil chemotaxis, phagocytosis, and microbicidal activity.

Authors:  Rahul Suresh Bhansali; Ramreddy Krishnarao Yeltiwar; Kishore Bhat
Journal:  J Indian Soc Periodontol       Date:  2017 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.